Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis-Reference-Cited by-同舟云学术

Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis

Published:2019-12-31 Issue:2 Volume:172 Page:86
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Conaghan Philip G.¹,Bowes Michael A.²,Kingsbury Sarah R.¹,Brett Alan²,Guillard Gwenael²,Rizoska Biljana³,Sjögren Niclas³,Graham Philippa³,Jansson Åsa³,Wadell Cecilia³,Bethell Richard³,Öhd John³

Affiliation:

1. Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom (P.G.C., S.R.K.)

2. Imorphics, Manchester, United Kingdom (M.A.B., A.B., G.G.)

3. Medivir, Huddinge, Sweden (B.R., N.S., P.G., Å.J., C.W., R.B., J.Ö.)

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Developments in Clinical Trials for Osteoarthritis: Are We Closer to Improving Pain Management and Disease Modification?;European Medical Journal;2024-09-12

2. Ultrasound Imaging in Knee Osteoarthritis: Current Role, Recent Advancements, and Future Perspectives;Journal of Clinical Medicine;2024-08-21

3. A comprehensive review of phase 2/3 trials in osteoarthritis: an expert opinion;Expert Opinion on Emerging Drugs;2024-08-05

4. Prospects of Disease-Modifying Osteoarthritis Drugs;Rheumatic Disease Clinics of North America;2024-08

5. Pain Reduction With Oral Methotrexate in Knee Osteoarthritis;Annals of Internal Medicine;2024-07-30